We are live on ! Find out more
HM

Harvest Management Portfolio holdings

AUM $206M
1-Year Est. Return 95.44%
This Fund
S&P 500
This Quarter Est. Return
+20.05%
1 Year Est. Return
+95.44%
3 Year Est. Return
+609.22%
5 Year Est. Return
+2,730.08%
10 Year Est. Return
+91,890.88%
AUM
$167M
AUM Growth
+$44.3M
Cap. Flow
+$37M
Cap. Flow %
22.14%
Top 10 Hldgs %
56.48%
Holding
91
New
50
Increased
9
Reduced
7
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 17.56%
2 Technology 16.38%
3 Industrials 9.26%
4 Consumer Discretionary 3.59%
5 Financials 1.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
51
Morgan Stanley
MS
$331B
$496K 0.3%
+6,391
New +$490K
LITE icon
52
PUT
Lumentum
LITE
$55.5B
$457K 0.27%
+5,000
New +$463K
CHNG
53
PUT
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$442K 0.26%
+20,000
New +$463K
BPFH
54
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$400K 0.24%
+30,000
New +$400K
BPFH
55
PUT
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$400K 0.24%
+30,000
New +$400K
OMCL icon
56
Omnicell
OMCL
$1.61B
$390K 0.23%
3,000
+1,000
+50% +$128K
MNR
57
DELISTED
Monmouth Real Estate Investment Corp
MNR
$354K 0.21%
+20,000
New +$353K
GT icon
58
PUT
Goodyear
GT
$2B
$351K 0.21%
+20,000
New +$290K
TMO icon
59
Thermo Fisher Scientific
TMO
$213B
$346K 0.21%
758
HIG icon
60
PUT
Hartford Financial Services
HIG
$38.9B
$334K 0.2%
+5,000
New +$270K
GNMK
61
PUT
DELISTED
GenMark Diagnostics, Inc
GNMK
$239K 0.14%
+10,000
New +$186K
GOOG icon
62
Alphabet (Google) Class C
GOOG
$4.36T
$207K 0.12%
+2,000
New +$198K
COHR icon
63
Coherent
COHR
$51.4B
$205K 0.12%
+3,000
New +$246K
MSGN
64
DELISTED
MSG Networks Inc.
MSGN
$199K 0.12%
+13,252
New +$222K
TBA
65
DELISTED
Thoma Bravo Advantage
TBA
$157K 0.09%
+15,000
New +$174K
PRDS
66
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$100K 0.06%
+10,000
New +$103K
CRNT icon
67
Ceragon Networks
CRNT
$197M
$41K 0.02%
11,000
+1,000
+10% +$4.4K
AAPL icon
68
Apple
AAPL
$4.54T
-1,520
Closed -$202K
AZN icon
69
AstraZeneca
AZN
$263B
-2,594
Closed -$259K
BMY icon
70
CALL
Bristol-Myers Squibb
BMY
$133B
-5,000
Closed -$310K
BMY icon
71
Bristol-Myers Squibb
BMY
$133B
-5,000
Closed -$310K
CRM icon
72
PUT
Salesforce
CRM
$151B
-10,000
Closed -$2.23M
GNW icon
73
Genworth Financial
GNW
$3.76B
-72,000
Closed -$272K
GNW icon
74
PUT
Genworth Financial
GNW
$3.76B
-72,000
Closed -$272K
LUMN icon
75
Lumen
LUMN
$6.57B
-12,540
Closed -$122K

Similar funds

Harvest Management's Q1 2021 Portfolio in Review

As of Q1 2021, Harvest Management held 91 positions worth $167M, up 36% from $123M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Harvest Management deployed $37M of net new capital in Q1 2021, opening 50 new positions and adding to 9 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 57,500 shares worth $8.79M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 7.6% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Willis Towers Watson, an estimated $5.47M trimmed.

  • Harvest Management's largest Q1 2021 buy was Alexion Pharmaceuticals: 57,500 shares worth $8.79M.
  • Harvest Management added most to INPHI CORPORATION in Q1 2021, an estimated $8.29M increase.
  • Harvest Management's biggest Q1 2021 reduction was Willis Towers Watson, cutting an estimated $5.47M.
  • Harvest Management fully exited Tiffany & Co. in Q1 2021, selling an estimated $17.4M.
  • Harvest Management's ten largest holdings make up 56% of its $167M portfolio in Q1 2021.
  • Harvest Management opened 50 new positions and closed 24 in Q1 2021.
  • Harvest Management's portfolio value rose 36% quarter-over-quarter to $167M.

Based on Harvest Management's 13F filing for Q1 2021, filed 4 May 2021.